5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia : A Population-Based Cohort Study
| dc.contributor.author | Doherty, Niamh | |
| dc.contributor.author | Cardwell, Chris R | |
| dc.contributor.author | Murchie, Peter | |
| dc.contributor.author | Hill, Christopher | |
| dc.contributor.author | Azoulay, Laurent | |
| dc.contributor.author | Hicks, Blánaid | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-01-04T00:16:52Z | |
| dc.date.available | 2024-01-04T00:16:52Z | |
| dc.date.embargoedUntil | 2024-01-04 | |
| dc.date.issued | 2023-03-06 | |
| dc.description | Financial Support: Dr’s B Hicks and CR Cardwell received funding from Cancer Research UK Population Research Fellowship (grant reference 22185). The funder had no role in the study design, analysis, interpretation or writing of the manuscript | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 7 | |
| dc.format.extent | 341694 | |
| dc.identifier | 226143909 | |
| dc.identifier | 61baabcc-af18-4c8d-97c1-7b44c0a0e864 | |
| dc.identifier | 36634196 | |
| dc.identifier | 85149999405 | |
| dc.identifier.citation | Doherty, N, Cardwell, C R, Murchie, P, Hill, C, Azoulay, L & Hicks, B 2023, '5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia : A Population-Based Cohort Study', Cancer Epidemiology, Biomarkers and Prevention, vol. 32, no. 3, pp. 428-434. https://doi.org/10.1158/1055-9965.EPI-22-1109 | en |
| dc.identifier.doi | 10.1158/1055-9965.EPI-22-1109 | |
| dc.identifier.iss | 3 | en |
| dc.identifier.issn | 1055-9965 | |
| dc.identifier.other | ORCID: /0000-0001-9968-5991/work/127817939 | |
| dc.identifier.uri | https://hdl.handle.net/2164/22496 | |
| dc.identifier.vol | 32 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cancer Epidemiology, Biomarkers and Prevention | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Benign prostatic hyperplasia | en |
| dc.subject | kidney cancer | en |
| dc.subject | bladder cancer | en |
| dc.subject | 5-alpha reductase inhibitor | en |
| dc.subject | epidemiology | en |
| dc.subject | R Medicine | en |
| dc.subject | Cancer Research UK | en |
| dc.subject | 22185 | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | 5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia : A Population-Based Cohort Study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Doherty_etal_CEBP_Alpha_Reductase_Inhibitors_AAM.pdf
- Size:
- 333.69 KB
- Format:
- Adobe Portable Document Format
